×
STERIS Cash on Hand 2010-2024 | STE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
STERIS cash on hand for the quarter ending September 30, 2024 was
$0.172B
, a
19.44% decline
year-over-year.
STERIS cash on hand for 2024 was
$0.207B
, a
0.64% decline
from 2023.
STERIS cash on hand for 2023 was
$0.208B
, a
40.18% decline
from 2022.
STERIS cash on hand for 2022 was
$0.348B
, a
57.95% increase
from 2021.
View More
STERIS Cash on Hand 2010-2024 | STE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
STERIS cash on hand for 2024 was
$0.207B
, a
0.64% decline
from 2023.
STERIS cash on hand for 2023 was
$0.208B
, a
40.18% decline
from 2022.
STERIS cash on hand for 2022 was
$0.348B
, a
57.95% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$194.7B
Intuitive Surgical (ISRG)
$191.9B
Alcon (ALC)
$42.1B
Edwards Lifesciences (EW)
$41.4B
IQVIA Holdings (IQV)
$34.7B
IDEXX Laboratories (IDXX)
$34.1B
DexCom (DXCM)
$29.2B
Waters (WAT)
$20.5B
SONOVA HOLDING (SONVY)
$20.3B
Hologic (HOLX)
$18.2B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.7B
Globus Medical (GMED)
$11.3B
Penumbra (PEN)
$9.1B
Teleflex (TFX)
$9B
Masimo (MASI)
$8.8B
Glaukos (GKOS)
$8B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.5B
Veracyte (VCYT)
$3B
Inari Medical (NARI)
$3B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.8B
Nihon Kohden (NHNKY)
$2.3B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$1.8B
RxSight (RXST)
$1.8B
Integra LifeSciences Holdings (IART)
$1.8B
Alphatec Holdings (ATEC)
$1.4B
Artivion (AORT)
$1.1B